Dechra Pharmaceuticals PLC (DPH.L) reported that its fiscal year underlying earnings per share grew by 19.4% year-on-year reflecting the profit growth from the existing and acquired businesses offset by higher net finance costs, tax charges and the full year impact of the equity placing in June 2020. Consolidated underlying operating profit was 162.2 million pounds, up 29.2%. The Group noted that this included 149.9 million pounds from Dechra's existing business, an increase of 19.5% on a like-for-like basis, and a 12.3 million pounds contribution from acquired businesses.
For the year ended 30 June 2021, pretax profit increased to 74.0 million pounds from 40.9 million pounds, prior year. Earnings per share was 51.03 pence compared to 32.76 pence. Underlying operating profit increased by 29.2% to 162.2 million pounds. Underlying earnings per share increased by 19.4% to 108.14 pence. Revenue rose 21.0% to 608.0 million pounds.
The Board proposed a final dividend of 29.39 pence per share. Added to the interim dividend, this brings the total dividend for the fiscal year to 40.50 pence per share.
For comments and feedback: editorial@rttnews.com